Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2026-08-09), DSM-Firmenich AG's 6-1 Month Momentum % is N/A%.
The industry rank for DSM-Firmenich AG's 6-1 Month Momentum % or its related term are showing as below:
XSWX:DSFIR's 6-1 Month Momentum % is not ranked *
in the Chemicals industry.
Industry Median: -1.75 * Ranked among companies with meaningful 6-1 Month Momentum % only.
DSM-Firmenich AG (XSWX:DSFIR) 6-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
DSM-Firmenich AG 6-1 Month Momentum % Related Terms
DSM-Firmenich AG (XSWX:DSFIR) 6-1 Month Momentum % Calculation
6-1 Month Momentum % is calculated as following:
6-1 Month Momentum %
=
( Price 1-month ago
/
Price 6-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG (XSWX:DSFIR) has a 6-1 Month Momentum % of N/A% as of Aug. 09, 2026. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on DSM-Firmenich AG and its competitors. According to the industry distribution chart, DSM-Firmenich AG ranks #355 out of 1628 companies in the Chemicals industry, placing it in the top 21.8%.
Is DSM-Firmenich AG's 6-1 Month Momentum % too high?
DSM-Firmenich AG's current 6-1 Month Momentum % is N/A%. Based on the distribution chart, DSM-Firmenich AG ranks #355 out of 1628 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, DSM-Firmenich AG has a GF Score™ of 31/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's 6-1 Month Momentum % compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #355 out of 1628 companies for 6-1 Month Momentum %. This places DSM-Firmenich AG in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-1 Month Momentum % for a Chemicals company?
A good 6-1 Month Momentum % depends on the Chemicals industry context. However, 6-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-1 Month Momentum % mean?
A high 6-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on DSM-Firmenich AG and its competitors. DSM-Firmenich AG's current 6-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF78.44, compared to a current price of CHF87.90 — trading 12.1% above its estimated fair value. The current 6-1 Month Momentum % is N/A%. DSM-Firmenich AG's overall GF Score™ is 31/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-1 Month Momentum % calculated?
6-1 Month Momentum % is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current 6-1 Month Momentum % is N/A% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of CHF87.90 is trading 12.1% above its estimated GF Value™ of CHF78.44.
GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.
Key valuation signals for XSWX:DSFIR:
6-1 Month Momentum %: N/A%
GF Value™: CHF78.44 vs. price of CHF87.90 (12.1% above fair value)
No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
31GF Score
Get the complete analysis for XSWX:DSFIR
6-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DSFIR has been successfully added to your 
